Request Trial
18 July 2025VideosAmericasJohn Rearick, Dechert | Michael Penn, BlueRock Therapeutics | Mark Stewart, Merck | Paul Fleming, Seaport Therapeutics | Robin Weatherhead, Ventus Therapeutics

WATCH: Enabling success—mastering s112 in the new era of life sciences patents

Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life sciences patents, as discussed at LSPN.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
WATCH: Kymera Therapeutics’ Sylvia Yip on in-house leadership
18 May 2026   LSIPR’s senior reporter Marisa Woutersen speaks with the director of IP at Kymera Therapeutics about the realities of in-house IP leadership and the growing challenge of “fast followers” in biotech.
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026   Isomorphic Labs said the funding round, led by venture firm Thrive Capital, would be used to further its drug design engine and support hiring targets.
Americas
BMS signs $15.2bn deal with China’s top pharma company
14 May 2026   The agreement is the latest in a string of major deals between Hengrui and multinational drugmakers, and will see the parties jointly develop assets while licensing others.


Editor's picks

UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026

Editor's picks

Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026
Europe
WIPR debuts Global In-House Elite 2026
26 March 2026

More features

WATCH: Kymera Therapeutics’ Sylvia Yip on in-house leadership
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
BMS signs $15.2bn deal with China’s top pharma company
Medtech company sues over seven patents for incontinence products
10x Genomics settles suit with rival and targets DNA sequencing startup
Trade secrets, AI and the new scrutiny of big damages awards
WATCH: Interview with Mythili Markowski, director at Regeneron
Teva can pursue monopoly claims over rival’s ‘exclusive pharmacy deal’